Microalbuminuria in children with sickle cell anemia

Blessing Abhulimen-Iyoha Imuetinyan1, Michael Ibadin Okoeguale, Gabriel Ofovwe Egberue

  • 1Department of Child Health, University of Benin Teaching Hospital, Benin City, Nigeria.

Insights

Microalbuminuria (MA) affects 20.3% of children with sickle cell anemia (SCA). Early screening for MA in SCA patients is crucial for detecting and managing potential kidney complications.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Public Health

Background:

  • Microalbuminuria (MA) is an early indicator of renal disease.
  • Sickle cell anemia (SCA) patients are susceptible to kidney complications.
  • MA prevalence in pediatric SCA is under-reported, especially in high-burden regions.

Purpose of the Study:

  • To determine the prevalence of microalbuminuria (MA) in children with sickle cell anemia (SCA).
  • To explore associations between MA and patient characteristics like age, sex, and weight.
  • To highlight the importance of routine MA screening in pediatric SCA management.

Main Methods:

  • Cross-sectional, descriptive study of 69 children with SCA (aged 1-16 years) in steady state.
  • Semiquantitative analysis of MA using early morning spot urine samples.
  • Evaluation of anthropometry, blood pressure, and packed cell volume.

Main Results:

  • The prevalence of MA was 20.3% among the studied children with SCA.
  • MA prevalence showed a non-significant trend towards higher rates in females (25.9%) vs. males (16.7%).
  • MA prevalence increased with age and was significantly associated with weight (P=0.033), but not hypertension history.

Conclusions:

  • Microalbuminuria occurs significantly in children with SCA, necessitating routine screening.
  • Early detection via MA screening can facilitate timely intervention for renal complications.
  • Proactive management strategies can be implemented to slow kidney function decline in SCA patients.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...